Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DC11335 Ombitasvir

Ombitasvir is an orally bioavailable and potent inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A).

1258226-87-7
DC11044 Omidenepag Isopropyl Featured

Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor; demonstrates excellent IOP-lowering activities following ocular administration in ocular normotensive monkeys, Omidenepag Isopropyl (OMDI) is a clinical candidate for the treatment of glaucoma.

1187451-19-9
DC22463 ON 146040

ON 146040 is a potent, dual PI3K/BCR-ABL inhibitor with IC50 of 14/20 nM for PI3Kα/δ , IC50 of 20 nM for BCR/ABL.

1404231-34-0
DC22186 ON108110

ON108110 (ON-108110, ON 108110) is a novel multi-kinase inhibitor of protein kinase CK2 (CK2α1/2, IC50=3/2 nM) as well as CDK4/6 (IC50=2-24 nM).

1415599-79-9
DC9927 ON1231320 Featured

ON1231320 is a potent selective inhibitor of Polo like kinase 2 (PLK2).

1312471-39-8
DC8137 Oncrasin 1 Featured

Oncrasin 1 is a proapoptotic substance. Induces abnormal nuclear aggregation of PKCι and suppressing RNA transcription.

75629-57-1
DC23492 ONO-3080573

ONO-3080573 is a potent LPA1 inhibitor with IC50 of 11 nM..

1802079-40-8
DC8358 ONO-4059(Tirabrutinib) Featured

ONO-4059 is a novel Small Molecule Dual Inhibitor Of Bruton’s Tyrosine Kinase (Btk) and Tec Kinase.

1351636-18-4
DC23689 ONO-6126

ONO-6126 is a potent and selective PDE4 inhibitor for the treatment of bronchial asthma and allergic conjunctivitis..

401519-28-6
DC23490 ONO-9780307

ONO-9780307 is a potent LPA1 inhibitor with IC50 of 27 nM..

856691-44-6
DC23491 ONO-9910539

ONO-9910539 is a potent LPA1 inhibitor with IC50 of 22 nM..

1802079-45-3
DC9610 ONO-AE3-208

ONO-AE3-208(AE 3-208) is an EP4 antagonist; suppresses cell invasion, migration, and metastasis of prostate cancer.

402473-54-5
DC22705 ONO-DI 004

ONO-DI 004 is a potent, selective EP1 agonist..

250605-97-1
DC4243 ONX-0914

ONX 0914 is an immunoproteasome inhibitor with potential treatment applications in autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease and lupus.

960374-59-8
DC9404 Opicapone Featured

Opicapone(BIA 9-1067) is a long-acting, peripherally selective inhibitor of catechol-O-methyltransferase.

923287-50-7
DC11905 Opiranserin

Opiranserin (VVZ-149, VVZ-000149) is a potent, selective, mixed glycine GlyT2 transporter blocker (IC50= 0.86 uM), purine P2X3 receptor antagonist (IC50=0.87 uM) and serotonin 5-HT2A receptor antagonist (IC50=1.3 uM).

1441000-45-8
DC7425 HQL-79

Orally active and specific inhibitor of human hematopoietic prostaglandin D synthase (H-PGDS) (IC50 = 6 μM). Antiallergic and anti-inflammatory.

162641-16-9
DC10394 Org-26576

Org 26576 is a AMPA receptor positive allosteric modulator.

100044-96-0
DC7218 Org 27569

Org 27569 is an allosteric modulator of cannabinoid CB1 receptor, induces a CB1 receptor state that is characterized by enhanced agonist affinity and decreased inverse agonist affinity.

868273-06-7
DC20483 Org 42599 free base

Org 42599 is a cell-permeant, allosterically binding, small-molecule agonist of luteinizing hormone (LH) receptor that rescues the folding and cell surface expression mutant mutant human LH receptors A593P and S616Y (EC50=70.8 nM)..

501444-88-8
DC21446 Org 42599

Org 42599 is a cell-permeant, allosterically binding, small-molecule agonist of luteinizing hormone (LH) receptor that rescues the folding and cell surface expression mutant mutant human LH receptors A593P and S616Y (EC50=70.8 nM)..

501444-89-9
DC21447 Orita-13

Orita-13 is potent inhibitor of Migration inhibitory factor (MIF) tautomerase activity with Ki of 17 uM..

485-63-2
Page 212 / Total 1557 FirstPrevNextLastGoto